Latest in News & Research
LAUNCH ALERT: FDA Approves IDP-126 Gel for Acne Vulgaris
The once-daily triple-combination topical acne treatment is approved for use in patients 12 years and older
Social Stigma Associated With Adult Facial Acne
Faces with acne rated as less attractive, trustworthy, confident, successful, dominant, and happy
LAUNCH ALERT: Bimzelx Approved For Moderate-to-Severe Plaque psoriasis
The groundbreaking injectable biologic agent demonstrates unprecedented efficacy in the treatment of psoriasis.
FDA Approves Nivolumab as Adjuvant Treatment for Melanoma
Approval granted for patients aged 12 years and older with stage IIB/C disease
Is Nonmelanoma Skin Cancer Causing More Deaths Than Melanoma?
Global melanoma incidence was 324,635 in 2020, resulting in 57,043 deaths, while 63,731 NMSC deaths were reported
Is Extensive Perineural Invasion Best Prognostic Measure for Cutaneous Squamous Cell Carcinoma?
Perineural invasion of five or more nerves independently linked to local recurrence, disease-specific death, any poor outcome
Half of Patients With Newly Diagnosed Vitiligo Do Not Receive Treatment
Proportion receiving treatment within 12 months higher with more severe disease
How Does Lesion Visibility Affect Melanoma Prognosis?
Patients with nonvisible lesions more likely to have T3 or T4 tumors, positive lymph nodes, higher-risk stage
Is Autologous Cell Transplant Reliable for Stable Segmental Vitiligo?
Cultivated cells have better results than noncultivated ones; both types pigment 80 percent or more where needed
Autoimmune, Autoinflammatory Connective Tissue Disorders Increased After COVID-19
Risks associated with COVID-19 severity
Risankizumab Treatment Beneficial in Real-World Psoriasis Cohort
High levels of clear and clear/almost clear skin, significant reductions in psoriasis symptoms reported at one year after initiation
Black Race Linked to Worse Survival in Kaposi Sarcoma
Survival benefit seen for Spanish/Hispanic ethnicity, private insurance, residence in areas of high educational attainment
Sexual, Gender Minorities With Chronic Skin Diseases More Likely to Face Barriers to Care
Cost and noncost barriers more likely for sexual and gender-minority patients with chronic inflammatory skin diseases
Children With Eczema More Likely to Have Allergic Contact Dermatitis
Children with atopic dermatitis more likely to have more than one positive patch test result
Vitiligo and Associated Comorbidities: A Review
The pigmentary disorder is linked to a host of autoimmune disorders, ocular and auditory abnormalities, and dermatologic conditions
Does Adding Optical Coherence Tomography Increase Detection of Recurrent, Residual BCC?
Area under curve 0.98 for clinical and dermatoscopic examination combined with OCT and 0.77 for clinical and dermatoscopic examination alone
Itching, Sleep Disturbance Impact QoL in Prurigo Nodularis
All patients with PN reported itch, pain associated with PN, bleeding or scabbing, and having dry skin
Reduced Mortality Risk Seen for Patients With Vitiligo
Lower all-cause and cause-specific mortality seen, including from infectious diseases, oncologic diseases, endocrine diseases
Both Ciclosporin, Methotrexate Effective for Severe Eczema in Children
Greater improvement seen in disease severity by 12 weeks with ciclosporin, but MTX was superior by 60 weeks
Study Looks at Treatment Patterns for Alopecia Areata
47.2 percent received no treatment on day of diagnosis; by one year, 71.8 percent were not receiving treatment
Coronary Microvascular Dysfunction ID'd in 31.5 Percent With Psoriasis
Independent association with CMD seen for higher PASI, longer disease duration, psoriatic arthritis, hypertension
Combo Treatments Efficacious for Generalized-Type Vitiligo
No difference seen in efficacy for NB-UVB treatment combined with tacrolimus 0.1 percent or calcipotriol/betamethasone dipropionate
Somatosensory Profiles Characterized in Hidradenitis Suppurativa
HS lesions insensitive to innocuous cold and warmth, noxious heat, and light touch compared with healthy pain-free controls
24 of 1274